Ebola Crisis Deepens as Testing Shortages Hamper Containment

The situation in the DRC has reached a breaking point, with major laboratories in North and South Kivu reporting a total depletion of testing kits. This supply crisis has left health workers unable to process a massive backlog of samples, effectively blinding response teams to the virus’s current trajectory. Dr. Krutika Kuppalli, a former WHO official, warned that the inability to rapidly confirm cases creates dangerous delays in isolation and treatment, allowing the pathogen to circulate unchecked through vulnerable populations.

Containment efforts are further complicated by deep-seated public skepticism and the insecurity of the affected regions. Contact tracing, once the cornerstone of the response, has fallen to just 56.5 percent, far below the 95 percent target required to suppress transmission. CDC modeling suggests that without immediate and robust interventions, the Bundibugyo strain could rival the scale of the 2014–2016 West Africa epidemic.

In response to the mounting pressure, international donors have begun to mobilize. The United States has committed an additional $38 million in funding, bringing its total contribution to over $200 million, while the European Union has pledged €11.5 million to bolster surveillance and provide essential diagnostic equipment. Meanwhile, vaccine developers are accelerating work on multiple prototypes, including mRNA-based candidates and vesicular stomatitis virus platforms, hoping to close the gap for a strain that currently lacks an approved vaccine or specific treatment.